Voloridge Investment Management
MEDP icon

Voloridge Investment Management’s Medpace MEDP Stock Holding History

Voloridge Investment Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Sell
2,553
-72,177
-97% -$33.3M 0.01% 691
2026
Q1 		$35.9M Sell
74,730
-64,631
-46% -$33.1M 0.14% 197
2025
Q4 		$78.3M Sell
139,361
-51,633
-27% -$29.3M 0.28% 85
2025
Q3 		$98.2M Sell
190,994
-39,848
-17% -$17.4M 0.33% 69
2025
Q2 		$72.5M Buy
230,842
+34,902
+18% +$10.5M 0.27% 93
2025
Q1 		$59.7M Buy
195,940
+31,732
+19% +$10.7M 0.22% 125
2024
Q4 		$54.6M Buy
164,208
+58,861
+56% +$20M 0.19% 151
2024
Q3 		$35.2M Sell
105,347
-17,131
-14% -$6.51M 0.13% 245
2024
Q2 		$50.4M Sell
122,478
-46,069
-27% -$18.2M 0.19% 161
2024
Q1 		$68.1M Buy
168,547
+16,041
+11% +$5.64M 0.25% 107
2023
Q4 		$46.7M Buy
152,506
+68,249
+81% +$18.4M 0.18% 150
2023
Q3 		$20.4M Sell
84,257
-9,472
-10% -$2.42M 0.1% 281
2023
Q2 		$22.5M Sell
93,729
-26,925
-22% -$5.59M 0.11% 262
2023
Q1 		$22.7M Sell
120,654
-8,514
-7% -$1.76M 0.11% 267
2022
Q4 		$27.4M Buy
+129,168
New +$25.8M 0.15% 195
2022
Q3 		– Sell
-66,643
Closed -$9.97M – 1536
2022
Q2 		$9.97M Buy
66,643
+64,656
+3,254% +$9.36M 0.05% 438
2022
Q1 		$325K Buy
1,987
+853
+75% +$141K ﹤0.01% 1261
2021
Q4 		$247K Buy
+1,134
New +$237K ﹤0.01% 1494
2020
Q4 		– Sell
-44,713
Closed -$5M – 1469
2020
Q3 		$5M Buy
+44,713
New +$5.17M 0.04% 445
2020
Q2 		– Sell
-41,571
Closed -$3.05M – 1400
2020
Q1 		$3.05M Sell
41,571
-45,675
-52% -$3.97M 0.09% 252
2019
Q4 		$7.33M Buy
87,246
+16,793
+24% +$1.3M 0.14% 179
2019
Q3 		$5.92M Buy
+70,453
New +$5.32M 0.1% 225
2019
Q2 		– Sell
-13,179
Closed -$777K – 944
2019
Q1 		$777K Buy
+13,179
New +$787K 0.02% 554
2018
Q4 		– Sell
-54,880
Closed -$3.29M – 454
2018
Q3 		$3.29M Buy
+54,880
New +$3M 0.07% 174

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Voloridge Investment Management's MEDP Position: Q2 2026 in Review

Voloridge Investment Management reduced its Medpace (MEDP) stake by 97% in Q2 2026, selling an estimated $33.3M and leaving 2,553 shares worth $1.35M. The position accounts for 0.01% of the portfolio, ranked #691.

Voloridge Investment Management first reported a position in MEDP in Q3 2018 and has held it in 24 quarters since. The position peaked at $98.2M in Q3 2025. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Voloridge Investment Management held 2,553 shares of Medpace worth $1.35M as of Q2 2026.
  • Voloridge Investment Management sold 72,177 Medpace shares in Q2 2026, an estimated $33.3M.
  • Medpace made up 0.01% of Voloridge Investment Management's portfolio in Q2 2026, its #691 holding.
  • Voloridge Investment Management first reported a position in Medpace in Q3 2018 and has held it in 24 quarters since.
  • Voloridge Investment Management's Medpace position peaked at $98.2M in Q3 2025.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Voloridge Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.